Article
Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled Comparison.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 20 Jun 2015
Gonzalez Brian D, Jim Heather S L, Booth-Jones Margaret, Small Brent J, Sutton Steven K, Lin Hui-Yi, Park Jong Y, Spiess Philippe E, Fishman Mayer N, Jacobsen Paul B
Abstract excerpt
PURPOSE: Men receiving androgen-deprivation therapy (ADT) for prostate cancer may be at risk for cognitive impairment; however, evidence is mixed in the existing literature. Our study examined the impact of ADT on impaired cognitive performance and explored potential demographic and genetic predi...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
